Loading viewer...
earnings
Format: PDF earnings
Evotec SE's interim financial statement for the first nine months of 2022, presented November 9, 2022. The document includes regulatory disclaimers and forward-looking statements regarding the company's business operations, financial performance, and strategic objectives for its pharmaceutical development and manufacturing operations.
presentation
earnings
17 Pages
Morgan Stanley
Action Construction Equipment Q1 FY23 Earnings Call
earningsearnings
19 Pages
Action Construction Equipment Limited
AIA Engineering Q1 FY2017-18 Earnings Investor Presentation
earningsearnings
9 Pages
AIA Engineering Limited
WESCO International Q4 2016 Earnings Webcast
earningsearnings
26 Pages
WESCO International